Welcome back to the fifth installment of “Dissertation Diaries.” This week, we will be highlighting Chantal Aaron, a fifth-year Ph.D. student in The Elizabeth Byrne Lab at the Tufts Graduate School of ...

The scourge of opioid addiction continues to run rampant in Tennessee, but a local movement is looking to stamp out this ...

The recent series of settlements linked with claims against advertising and pharmaceutical manufacturing companies involved in the sales and marketing of opioid drugs are encouraging, demanding ...

The opioid crisis refers to the rapid increase in opioid overuse, misuse, and overdose deaths since the 1990s. It involves both prescription opioids and opioids that people use recreationally. People ...

For people who study the opioid epidemic, 2025 marks a grim anniversary: It has been 30 years since the Food and Drug Administration approved the opioid OxyContin for the treatment of chronic pain.

Scientists may be one step closer toward more effective treatments for opioid overdose after a new compound was discovered to improve the success rates of existing treatments. America has been in the ...

An FDA advisory panel voted in favor of approving the drug in early October. The FDA announced on Friday that it would side with its advisory panel by approving a new opioid drug, called Dsuvia, ...

Tennessee will receive more than $1.2 billion in opioid settlement funds. Experts fear the money isn’t reaching people who ...

For the first time in 25 years, the U.S. Food and Drug Administration has approved a new type of painkiller. Suzetrigine, sold as Journavx, is administered twice daily in 50-milligram oral tablets to ...